iMBP is committed to driving change in the industry. Explore our press releases, latest podcasts, and thought-provoking articles to stay informed and be part of our journey toward a brighter future in biopharma.
January, 2025
In December, an opportunity was presented to Dr. Kiernan to establish a team for the XPrize Healthspan competition. If you have never heard of XPrize, it is a global impact organization that has established a series of incentive competitions to drive solutions for system change. The competition of interest is XPrize Healthspan, a 7-year, $101 million global competition to revolutionize how we approach human aging.
A new and emerging field of science, healthspan is defined as the window in time in which a person is free of disease, and the goal is how does one expand this time window. Serving as the Principal Investigator for this program, the submitted application was a hybrid solution combining stem cell restorative medicine, bioactive peptide therapeutic enhancement, and functional exercise. With iMBP directly supporting the therapeutic protocol, we have teamed with Total Motion 360 and Restore Health AZ to perform the functional exercise and stem cell components. Along with several industry and academic advisors, these efforts matriculated into establishing Team Everest.
With applications due on 12/31/24, we proudly announce that Team Everest is a registered applicant. We now need to wait for the semi-final selection in March. Stay tuned until we hear more. To learn more about XPrize Healthspan, please click here.
December, 2024
Daily Grit is a top news source for startups, covering areas of tech, entrepreneurship, and funding. This article dives into Dr. Kiernan’s journey in the founding and current development of iMBP. Being a startup founder is not for everyone, and the “grit” it takes makes his personal story a bedrock foundation for a company that will endure and ultimately succeed. You can read the full article here.
December, 2024
The Decoding Health Podcast broke 55,000 views, a massive milestone for a new media outlet. Dr. Kiernan and the producers hope that you have been able to engage the podcast and have found the information informative. This month, we would like to highlight a recent episode in which Dr. Kiernan addresses some of the benefits of the ketogenic diet on brain function.
November, 2024
Dr. Kiernan was invited to NYC to participate in the Beyond Activ Conference in the health and wellness space. As an industry insider, he was brought in to give thoughts and analysis regarding integrating wellness and medicine. As the fitness world is reacting to pressures stemming from the use of Wegovy and Zepbound, they recognize that a biopharma insider perspective is important. This was a tremendous opportunity to bring iMBP to the forefront in a new industry and plant the flag as an industry leader in both mindset and innovation.
We are not big pharma, and we are not plagued by the same inefficiencies and problems that keep significant therapeutic innovation from ever reaching the patients who need it. Now aligned with several key industry leaders, this has opened the door for iMBP to find support from people with fresh perspectives and ideas. Together, we have the potential to make a holistic improvement in society.
November, 2024
We are honored to share that iMBP was featured in the Venture Beat alongside a number of other inspiring startup companies that are making a difference today.
The VentureBeat is a high-profile investor publication that shows that iMBP is getting noticed. We have also issued our press release formally announcing our second NIH SBIR grant award. Featured in Yahoo Finance, this announcement is being seen by thousands of readers around the world. Again, slowly but surely the iMBP story is building within the investor community. Read the article.
November, 2024
We received word last week that our application to the NIH, titled “Therapeutic Approach to Clear sdLDL from Circulation,” was awarded by the National Heart, Lung and Blood Institute (NHLBI). We received the Notice of Award on September 15, 2024, and the iMBP team is eager to start. This is our second therapeutic Small Business Innovative Research (SBIR) grant from the NHLBI. As this award was just announced, the formal press release has not been prepared, so be on the watch for that in next Month’s Newsletter.
October, 2024
Dr. Kiernan was recently interviewed on the DNA of Things Podcast. Hosted by Dr. Jeremy Koenig, our Founder and CEO was able to share his journey in life and science, culminating in the formation and development of iMBP into what it is today. You can listen to the full episode here.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.